FidoCure^® Veterinary Team Blog

History and Treatment Planning

A 12 year old, neutered male Golden Retriever, underwent a dental prophylaxis procedure performed by his primary care veterinarian in June of 2021. At that time, no suspicious lesions or growths were noted. In October 2021, his family discovered a marble-sized growth in his mouth along the gum line of his left maxilla. The mass was visible from the outside of his mouth, and seemed to cause him irritation. At the time, it was bloody (perhaps from self trauma/stick chewing). Antibiotics were prescribed, but the dog quickly developed worsening clinic signs (nasal discharge, swelling, lethargy). 

Exclusive fireside chat with a distinguished trio of cancer experts: Dr. Len Lichtenfeld former Deputy Chief Medical Officer for the American Cancer Society (and FidoCure Scientific Advisory Board Member) with Dr. Gerry Post, Chief Medical Officer, FidoCure and Christina Lopes, CEO, FidoCure.

Hear first-hand about their 8-year journey together in the fight against cancer on both ends of the leash.

 

Canine cancer is a heartbreaking diagnosis that affects millions of beloved pets worldwide. In fact, it’s one of the biggest unmet needs in veterinary medicine. As advancements in our field continue to evolve, FidoCure emerges as a groundbreaking solution, offering a revolutionary approach to treating canine cancer. By harnessing the power of genomic testing, FidoCure provides targeted therapies that are transforming the landscape of canine cancer care.

FOR IMMEDIATE RELEASE

Dr. Ehrhart shares insight from her current work in comparative aging research and highlights its intersection with cancer and musculoskeletal research in veterinary medicine.

Genomics is fast becoming an essential part of veterinary oncology. It touches upon all aspects of practice, from diagnostics to therapeutics. Genetic information can be incredibly useful in terms of making a more accurate diagnosis or making a more precise prognosis, or even determining what therapy to use or what order to use different therapies.

Cancer is one of the biggest unmet needs in the veterinary world, despite the fact that canine cancer research shares a great deal of overlap with human oncology. Genomic testing and targeted therapies have been used for years in human cancer treatment, so it’s not surprising that recent advancements in genomic testing have proven valuable in the field of canine cancer research and treatment. FidoCure, a leading pioneer in this field, is transforming the way veterinarians approach cancer treatment for our beloved canine companions. In this blog, we will explore the cutting-edge benefits of genomic testing and how FidoCure is revolutionizing canine cancer treatment while also providing much-needed support and hope for families.